{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:49:55Z","timestamp":1771465795587,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.3816\/clm.2008.n.013","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:57Z","timestamp":1221095457000},"page":"111-116","source":"Crossref","is-referenced-by-count":36,"title":["Osteonecrosis of the Jaw in Patients with Multiple Myeloma Treated with Bisphosphonates: Definition and Management of the Risk Related to Zoledronic Acid"],"prefix":"10.3816","volume":"8","author":[{"given":"Anna Maria","family":"Cafro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Barbarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Nosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"D'Avanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Nichelatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Bibas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Gaglioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Taroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"D'Avanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Andriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2008.n.013_bib1","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CLM.2008.n.013_bib2","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1210\/en.137.6.2324","article-title":"Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclastic mediated resorption","volume":"137","author":"Vitt\u00e9","year":"1996","journal-title":"Endocrinology"},{"key":"10.3816\/CLM.2008.n.013_bib3","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2008.n.013_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jbmr.5650050107","article-title":"Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy","volume":"5","author":"Sato","year":"1990","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CLM.2008.n.013_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1749-6632.1999.tb07702.x","article-title":"MMP inhibition and downregulation by bisphosphonates","volume":"878","author":"Teronen","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.3816\/CLM.2008.n.013_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.3816\/CLM.2008.n.013_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of jaw associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.3816\/CLM.2008.n.013_bib8","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.013_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2005.05382.x","article-title":"Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma","volume":"128","author":"Vannucchi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.n.013_bib10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonates compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3816\/CLM.2008.n.013_bib11","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in ventral prostate in castrated rats","volume":"15","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.n.013_bib12","series-title":"Aredia product information","author":"Novartis Pharmaceuticals Australia","year":"2004"},{"key":"10.3816\/CLM.2008.n.013_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2008.n.013_bib14","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.013_bib15","first-page":"968","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid","volume":"91","author":"Dimopoulos","year":"2006","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2008.n.013_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/asheducation-2006.1.356","article-title":"Bisphosphonate complications including osteonecrosis of the jaw","volume":"515","author":"Mehrotra","year":"2006","journal-title":"Hematology"},{"key":"10.3816\/CLM.2008.n.013_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JOP.2.1.7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J Oncol Pharm Pract"},{"key":"10.3816\/CLM.2008.n.013_bib18","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.joms.2007.03.019","article-title":"Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series","volume":"65","author":"Freiberger","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.3816\/CLM.2008.n.013_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.2005.04.2465","article-title":"Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors","volume":"24","author":"Badros","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.013_bib20","first-page":"750","article-title":"Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: a retrospective study","volume":"23","author":"Estilo","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.n.013_bib21","doi-asserted-by":"crossref","first-page":"308b","DOI":"10.1182\/blood.V104.11.4905.4905","article-title":"Oral cavity avascular bone necrosis -a newly recognized complication of intravenous (IV) bisphosphonate therapy in cancer patients","volume":"104","author":"Schuster","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.013_bib22","doi-asserted-by":"crossref","first-page":"315b","DOI":"10.1182\/blood.V104.11.4933.4933","article-title":"Osteonecrosis of the jaw in myeloma patients receiving pamidronate or zoledronate","volume":"104","author":"Kut","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.013_bib23","first-page":"S131","article-title":"Osteonecrosis of the jaw in patients with metastatic breast cancer","volume":"88","author":"Van Poznak","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CLM.2008.n.013_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.3816\/CLM.2008.n.013_bib25","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J Can Dent Assoc"},{"key":"10.3816\/CLM.2008.n.013_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med J Aust"},{"key":"10.3816\/CLM.2008.n.013_bib27","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1600-051X.2005.00842.x","article-title":"Osteonecrosis of jaw in periodontal patients with a history of bisphosphonates treatment","volume":"32","author":"Ficarra","year":"2005","journal-title":"J Clin Periodontol"},{"key":"10.3816\/CLM.2008.n.013_bib28","doi-asserted-by":"crossref","first-page":"512a","DOI":"10.1182\/blood.V106.11.5152.5152","article-title":"Osteonecrosis of the jaw associated with chronic bisphosphonate therapy: an Italian experience","volume":"106","author":"Cafro","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.013_bib29","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper [published erratum in: J Am Dent Assoc 2006; 137:26]","volume":"136","author":"Migliorati","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"10.3816\/CLM.2008.n.013_bib30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","article-title":"Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients","volume":"134","author":"Zervas","year":"2006","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.n.013_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.joms.2006.03.002","article-title":"Why osteonecrosis of the jaw after bisphosphonate treatment is more frequent in multiple myeloma than in solid tumors","volume":"64","author":"Delibasi","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.3816\/CLM.2008.n.013_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment [published erratum in: Lancet Oncol 2006; 7:533]","volume":"7","author":"Migliorati","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.3816\/CLM.2008.n.013_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.3816\/CLM.2008.n.013_bib34","doi-asserted-by":"crossref","first-page":"965a","DOI":"10.1182\/blood.V106.11.3460.3460","article-title":"Role of ozone therapy in the treatment of osteonecrosis of the jaw in multiple myeloma patients","volume":"106","author":"Gallucci","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.013_bib35","first-page":"268","article-title":"Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter","year":"2003","journal-title":"Aust Dent J"},{"key":"10.3816\/CLM.2008.n.013_bib36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaw associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.3816\/CLM.2008.n.013_bib37","doi-asserted-by":"crossref","first-page":"216a","DOI":"10.1182\/blood.V104.11.756.756","article-title":"Osteonecrosis of the jaws in myeloma: time dependent correlation with Aredia\u00aeand Zometa\u00ae","volume":"104","author":"Durie","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.n.013_bib38","doi-asserted-by":"crossref","first-page":"313b","DOI":"10.1182\/blood.V104.11.4925.4925","article-title":"Bisphosphonate therapy associated with an increased incidence of mandibular\/maxillary osteomyelitis in multiple myeloma patients","volume":"104","author":"Thakkar","year":"2004","journal-title":"Blood"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:10:05Z","timestamp":1588918205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1557919011702177"],"URL":"https:\/\/doi.org\/10.3816\/clm.2008.n.013","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}